Vertex Pharmaceuticals Incorporated

VRTXNASDAQHealthcare● Active

$443.01

$-3.82(-0.86%)

Market Cap$112.4B

P/E Ratio—

52W High$507.92

52W Low$362.5

Avg Volume1.3M

Open$443.17

Beta0.31

Overview

Vertex Pharmaceuticals Incorporated (VRTX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

VRTX · net income · updated Jun 8, 2026

Core profitability metrics

VRTX · net income · margin · TTM · CAGR

Net income was $3.95B for FY2025 (fiscal year ending 2025-12-31), up 838.1% year-over-year. Net profit margin was 32.7%. Based on available data, Vertex Pharmaceuticals Incorporated has been profitable since at least 2011.

FY2025 Net Income$3.95B▲ +838.1% YoY

Trailing 12M (TTM)$4.34Btrailing 4 quarters sum

Net Profit Margin32.7%$3.95B ÷ $12.07B

YoY Change+838.1%—

5-Year CAGR+7.8%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · VRTX net income history · VRTX profit margin

Annual net income data

VRTX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$3.95B▲ +838.1%32.7%$12.07B

FY2024Loss−$535.6M▼ 114.8%-4.9%$11.02B

FY2023$3.62B▲ +9.0%36.7%$9.87B

FY2022$3.32B▲ +41.8%37.2%$8.93B

FY2021$2.34B▼ 13.6%30.9%$7.57B

Net income vs peers (Healthcare)

VRTX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Vertex Pharmaceuticals IncorporatedYOU

VRTX

$3.95B+838.1%32.7%

15%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Vertex Pharmaceuticals Incorporated (VRTX) reported net income of $3.95B for FY2025 (fiscal year ending 2025-12-31), up 838.1% year-over-year. The net profit margin was 32.7% — meaning the company kept $0.33 of every dollar of revenue as profit.

Based on available data, Vertex Pharmaceuticals Incorporated has been profitable since at least 2011. Net income reached a peak of $3.95B in FY2025. Data available for 15 fiscal years.

Vertex Pharmaceuticals Incorporated's net profit margin was 32.7% for FY2025, based on the latest annual results.

Investors sometimes search for "Vertex Pharmaceuticals Incorporated net worth" — the company's market capitalization is a separate figure from VRTX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

VRTX net income · 5 questions

Vertex Pharmaceuticals Incorporated is profitable. The company reported net income of $3.95B for FY2025, a net profit margin of 32.7%. Net income was up 838.1% year-over-year. Based on available data, Vertex Pharmaceuticals Incorporated has been profitable since at least 2011.

is VRTX profitabledoes VRTX make a profitVRTX profitabilityVRTX profitable company

▸ Source: FMP /income-statement · GAAP · Vertex Pharmaceuticals Incorporated · Vertex Pharmaceuticals Incorporated SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026